Our mantra for Sponsors and CRO’s is:
"To ensure the success of your trial - It’s our job to remove the variables before the trial starts."
To enable this the Fusion Business Enablers include:
Fusion Marketing
Our specialist Marketing Team utilises social media, radio, public relations and access to our general practice and specialist network.
Fusion Database
More than 8000 participants are on our active data base ensuring recruitment targets are met.
Fusion Participant Engagement and Scheduling Team
Enables and achieves a high volume of registrations and enrolments for trials; Schedules all participant trial appointments
Fusion Study Team
Involved from start-up through to close out; Responsible for trial management and coordination; Provide data and laboratory services; Guarantee quality assurance.
Medical and Nursing Team
An experienced team of principal investigators, Doctors and nurses undertaking consent, screening, assessment, dosing, review and continuity of care.
Business Development Team
Development of proposals, budgets and contracts to meet sponsors and CRO needs; Liaison and relationship management with general practice and specialists.
Recent Fusion trials
Vaccinations
-
Pneumococcal
-
Norovirus
-
RSV
-
COVID-19
-
Influenza
-
Combination Vaccines (COVID-19/influenza)
Medical Conditions and Disease
-
Mental Health
-
Sleep Disorders
-
Cardiac
-
Obesity and metabolic disorders
-
Diabetes
-
Dermatology
Are you interested in partnering with Fusion Clinical Research to conduct a clinical trial?
Our expertise
We are based in the medical hub of central Adelaide, adjacent to the Royal Adelaide Hospital and The South Australian Health and Medical Research Institute (SAHMRI), home to more than 700 medical researchers working together to tackle the biggest health challenges in society today.
Australia is home to some of the world's best researchers and health professionals and boasts a world-class research infrastructure, a stable socio-political environment, and high standards that ensure confidence in the scientific conclusions reached by clinical trials conducted in Australia.
Australia has an efficient regulatory pathway for clinical trials. Under the Clinical Trials Notification (CTN) scheme administered by the Therapeutic Goods Administration (TGA), research proposals are submitted directly to Australian Human Research Ethics Committees (HRECs) which assume the primary review responsibility for ethical and scientific review. The usual review cycle takes only 4 to 8 weeks.
The Australian Government’s generous Research & Development (R&D) tax incentive encourages investment in medical R&D. The Incentive provides for increased access by international companies. In particular, there is no requirement to hold the intellectual property in Australia. Increased level of expenditure that can be claimed on R&D activities undertaken overseas in support of Australian R&D projects, under certain conditions.
Above all, the new system provides a globally competitive tax incentive for conducting R&D activities in Australia. More information about the R&D Tax Incentive can be found at www.business.gov.au
Our experienced team comprises nurses, scientists and technicians who are practised in client services and patient care; trial start-up activities and trial execution with access to a broad patient population through an extensive GP and specialist clinic network. Fusion Clinical Trials studies are supported by trusted and tested CMAX Clinical Research systems and processes.